Instrument Inactif

Gouvernance Active Biotech AB Other OTC

Recherche biotechnologique et médicale

Comité Exécutif: Active Biotech AB

Dirigeant

Fonctions occupéesDepuis

Helén Tuvesson

64 ans

Chief Executive Officer	01/07/2017
Investor Relations Contact	-
President	01/07/2017

Hans Kolam

75 ans

Director of Finance/CFO	01/01/2000
Public Communications Contact	01/01/2000

Erik Vahtola

Chief Tech/Sci/R&D Officer

01/01/2022

Composition du Conseil d'Administration: Active Biotech AB

Administrateur

ComitésDepuis

Michael Shalmi

61 ans

Audit Committee Chair	23/05/2019
Nominating Committee Chair	23/05/2019

Karl Peter Thelin

70 ans

Audit Committee	07/04/2011
Nominating Committee	07/04/2011

Axel Gaston Glasmacher

66 ans

Compensation Committee

Uli Alf Hacksell

76 ans

Audit Committee

23/05/2019

Aleksandar Danilovski

52 ans

Director/Board Member	01/01/2020
Independent Dir/Board Member	01/01/2020

Anciens Dirigeants et Administrateurs: Active Biotech AB

Insider

Fonctions occupées

DepuisJusqu'au

Helena Eriksson

Chief Tech/Sci/R&D Officer

01/01/2017

01/12/2021

Peter Sjöstrand

Director/Board Member	01/01/2000	01/05/2020
Independent Dir/Board Member	01/01/2000	01/05/2020

Elaine Sullivan

Director/Board Member	01/05/2020	-
Independent Dir/Board Member	01/05/2020	-

Mats Georg Arnhög

Director/Board Member	01/01/2000	01/01/2003
Chairman	01/01/2003	23/05/2019
Independent Dir/Board Member	01/01/2000	23/05/2019

Magnhild Sandberg-Wollheim

Director/Board Member	01/01/2007	23/05/2019
Independent Dir/Board Member	01/01/2007	23/05/2019

Tomas Leanderson

Chief Executive Officer	01/01/1999	01/07/2017
Investor Relations Contact	01/01/1999	01/07/2017
Public Communications Contact	01/01/1999	01/07/2017
President	01/01/1999	01/07/2017

Anette Sundstedt

Director/Board Member

01/01/2001

01/01/2016

Karin Aschan

General Counsel

01/12/2009

01/12/2015

Göran Forsberg

Investor Relations Contact	01/01/1998	01/08/2014
Public Communications Contact	06/05/2010	01/08/2014

Ingela Fritzson

Director/Board Member

01/01/2014

Helena Karlsson

Director/Board Member

01/01/2014

Rolf Valter Rikard Kiessling

Director/Board Member

15/05/2013

Peter Jan Sture Ström

Director/Board Member

01/01/2013

Mef Nilbert

Director/Board Member

14/06/2011

Sten Peter Hofvenstam

Director/Board Member

07/04/2011

Sven Arne Andréasson

Chief Executive Officer

01/02/1999

01/09/2008

Klas Kärre

Director/Board Member

01/01/2003

Malin Sundbäck

Corporate Officer/Principal

01/08/1997

30/09/2000

Mats Blom

Director of Finance/CFO

01/01/1998

01/01/2000

Karin Hallbeck

Director/Board Member

06/05/2010

Camilla Gummesson

Director/Board Member

01/01/1998

Mats Olof Magnus Lidgard

General Counsel

Dorthe da Graça Thrige

Corporate Officer/Principal

David Liberg

Corporate Officer/Principal

Linda Bengtsson

Comptroller/Controller/Auditor

Kasim Kutay

Director/Board Member

Mats Hansen

Corporate Officer/Principal

Simon Kerry

Corporate Officer/Principal

Mats Gunnar Pettersson

Director/Board Member

Lena Birgitta Degling Wikingsson

Corporate Officer/Principal

Björn Magnus Sjöstrand

Chief Operating Officer	08/01/2013	-
Chief Tech/Sci/R&D Officer	08/01/2013	-
Corporate Officer/Principal	-	08/01/2013

Karin Hannader

Corporate Officer/Principal

Cecilia Hofvander

Public Communications Contact

Bo Krister Håkansson

Chief Executive Officer	-	-
President	-	-

Tomas Nicolin

Director/Board Member

06/05/2010

Steven Powell

Corporate Officer/Principal

Distribution de l'Âge des Dirigeants

Parité Homme Femme

Homme	8
Femme	0

Dont comité exécutif

Homme	3
Femme	0

Dont Administrateurs

Homme	5
Femme	0

Active Biotech AB (publ) est une société suédoise qui développe des produits pharmaceutiques dans des domaines médicaux où la défense immunitaire est importante, notamment le cancer et les maladies inflammatoires. Le portefeuille de projets comprend à la fois des petites molécules immunomodulatrices actives par voie orale et des immunothérapies à base d'anticorps.

Employés

Secteur

Recherche biotechnologique et médicale

Agenda

20/08 Publication des résultats - Q2 2026

Plus d'informations sur la société